mardi 8 septembre 2020

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

High-intensity focused ultrasound (HIFU) - a technology used to treat localized prostate cancer - has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

Aucun commentaire:

Enregistrer un commentaire